Home » Stocks » EW » Company

Edwards Lifesciences Corporation (EW)

Stock Price: $109.40 USD 2.34 (2.19%)
Updated Jul 23, 2021 4:00 PM EDT - Market closed
Edwards Lifesciences Corporation
Country United States
Founded 1958
IPO Date Mar 27, 2000
Industry Medical Devices
Sector Healthcare
Employees 14,900
CEO Michael Mussallem

Contact Details

Address:1 Edwards Way
Irvine, California 92614-5688
United States
Phone 949 250 2500

Stock Information

Ticker Symbol EW
Exchange NYSE
Fiscal Year January - December
Reporting Currency US Dollars
CIK Code 0001099800
CUSIP Number 28176E108
ISIN Number US28176E1082
Employer ID 36-4316614

Company Description

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally.

It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases.

The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery.

In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure.

The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Key Executives

Michael A. MussallemChairman and Chief Executive Officer
Scott B. UllemCorporate Vice President and Chief Financial Officer
Donald E. Bobo Jr.Corporate Vice President of Strategy and Corporate Development
Larry L. WoodCorporate Vice President of Transcatheter Aortic Valve Replacement
Jean-Luc LemercierCorporate Vice President of Europe, Middle East, Africa, Canada and Latin America
Dr. Todd J. BrintonCorporate Vice President of Advanced Technology and Chief Scientific Officer
Mark WilterdingVice President of Investor Relations
Arnold A. PinkstonCorporate Vice President and General Counsel
Dirksen J. LehmanCorporate Vice President of Public Affairs
Christine Z. McCauleyCorporate Vice President of Human Resources